N6 -(2-Deoxy-d- erythro-pentofuranosyl)-2,6-diamino-3,4-dihydro-4-oxo-5- N-(2-hydroxy-3-buten-1-yl)-formamidopyrimidine Adducts of 1,3-Butadiene: Synthesis, Structural Identification, and Detection in Human Cells

Chemical Research in Toxicology
Arnold S GroehlerN Y Tretyakova

Abstract

1,3-Butadiene (BD) is an environmental and occupational toxicant classified as a human carcinogen. BD is metabolically activated by cytochrome P450 monooxygenases to 3,4-epoxy-1-butene (EB), which alkylates DNA to form a range of nucleobase adducts. Among these, the most abundant are the hydrolytically labile N7-guanine adducts such as N7-(2-hydroxy-3-buten-1-yl)-guanine (N7-EB-dG). We now report that N7-EB-dG can be converted to the corresponding ring open N6-(2-deoxy-d- erythro-pentofuranosyl)-2,6-diamino-3,4-dihydro-4-oxo-5- N-(2-hydroxy-3-buten-1-yl)-formamidopyrimidine (EB-Fapy-dG) adducts. EB-Fapy-dG lesions were detected in EB-treated calf thymus DNA and in EB-treated mammalian cells using quantitative isotope dilution nanoLC-ESI+-MS/MS. EB-Fapy-dG adduct formation in EB-treated calf thymus DNA was concentration dependent and was greatly accelerated at an increased pH. EB-FAPy-dG adduct amounts were 2-fold higher in base excision repair-deficient NEIL1-/- mouse embryonic fibroblasts (MEF) as compared to isogenic controls (NEIL1+/+), suggesting that this lesion may be a substrate for NEIL1. Furthermore, NEIL1-/- cells were sensitized to EB treatment as compared to NEIL1+/+ fibroblasts. Overall, our results indicate that r...Continue Reading

References

Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G McMahonG N Wogan
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T Shimada, F P Guengerich
Jul 11, 1988·Nucleic Acids Research·T R O'ConnorJ Laval
Jan 27, 1983·Biochemical and Biophysical Research Communications·S Boiteux, J Laval
Feb 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·E A BaileyJ M Essigmann
Jul 20, 1999·Chemical Research in Toxicology·H KocJ A Swenberg
Jan 29, 2000·Chemical Research in Toxicology·J R CarmicalR S Lloyd
Feb 3, 2000·Free Radical Biology & Medicine·M A GraziewiczB Tudek
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tapas K HazraSankar Mitra
Jul 5, 2002·The Journal of Biological Chemistry·Tapas K HazraTadahide Izumi
Jan 25, 2003·Journal of Biochemistry and Molecular Biology·Barbara Tudek
Oct 23, 2003·Nature Reviews. Cancer·Stephen S Hecht
Dec 23, 2003·The Journal of Biological Chemistry·Patrick J O'Brien, Tom Ellenberger
Jul 20, 2004·Chemical Research in Toxicology·Kent S GatesSanjay Dutta
Oct 14, 2005·The Journal of Biological Chemistry·Jingping HuVilhelm A Bohr
Sep 1, 1967·Applied Microbiology·A F SchindlerW V Eisenberg
Feb 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Vladimir VartanianR Stephen Lloyd
Nov 25, 2006·Chemico-biological Interactions·Hong ChengElizabeth Delzell
Jan 11, 2007·Journal of Environmental Monitoring : JEM·Pernilla GustafsonGerd Sällsten
Nov 1, 1948·Journal of the American Chemical Society·L F CAVALIERI, A BENDICH
May 26, 2009·Mutation Research·Gunnar BoysenJames A Swenberg

❮ Previous
Next ❯

Citations

Mar 17, 2020·Chemical Research in Toxicology·Haoqing ChenRobert J Turesky
Mar 12, 2021·Carcinogenesis·Caitlin C Jokipii KruegerNatalia Tretyakova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here